Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewImmunologyPulmonology Open Access | 10.1172/jci.insight.189205

Cycloxygenase-2 negatively regulates innate lymphoid cell type 2 differentiation and function during allergic lung inflammation

Hong Li,1 Matthew L. Edin,1 Daniel Menendez,1 J. Alyce Bradbury,1 Joan P. Graves,1 Artiom Gruzdev,1 Gregory S. Whitehead,1 Maria I Sifre,1 Laura M. DeGraff,1 and Darryl C. Zeldin1

1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America

Find articles by Li, H. in: PubMed | Google Scholar

1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America

Find articles by Edin, M. in: PubMed | Google Scholar |

1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America

Find articles by Menendez, D. in: PubMed | Google Scholar

1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America

Find articles by Bradbury, J. in: PubMed | Google Scholar

1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America

Find articles by Graves, J. in: PubMed | Google Scholar

1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America

Find articles by Gruzdev, A. in: PubMed | Google Scholar

1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America

Find articles by Whitehead, G. in: PubMed | Google Scholar |

1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America

Find articles by Sifre, M. in: PubMed | Google Scholar

1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America

Find articles by DeGraff, L. in: PubMed | Google Scholar

1Division of Intramural Research, National Institutes of Health, Research Triangle Park, United States of America

Find articles by Zeldin, D. in: PubMed | Google Scholar

Published September 22, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.189205.
Copyright © 2026, Li et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published September 22, 2026 - Version history
View PDF
Abstract

Type 2 innate lymphoid cells (ILC2) are a population of lineage-negative cells in the lung, gastrointestinal tract, and skin which have emerged as a significant component of type 2 allergic inflammation. The regulation of cyclooxygenase-2 (COX-2) metabolites is critical to the pathophysiology of many inflammatory disorders, including allergic asthma. While COX-2 regulates Th9 and Th17 cell differentiation and function during allergic lung inflammation, it remains unknown whether COX-2 also regulates ILC2 cell differentiation and function under similar conditions. To address this question, we examined lung ILC2 cells from COX-2+/+ and COX-2-/- mice after ovalbumin (OVA)- or Alternaria-induced allergic lung inflammation. ILC2 cells were significantly increased in COX-2-/- lungs compared with COX-2+/+ lungs after OVA exposure in vivo. The increase in ILC2 cells was accompanied by an increase in expression of the cytokines IL-5 and IL-13, and the transcription factor GATA3. Both genetic disruption and selective inhibition of COX-2 significantly increased ILC2 cell differentiation from isolated common lymphoid progenitor cells (CLP) in vitro. Furthermore, COX-2-derived PGE2 acting via EP2 receptors significantly reduced IL-33 and TSLP expression, and attenuated ILC2 cell differentiation in vitro and in vivo. Thus, during allergic lung inflammation, COX-2-derived PGE2 signals through the EP2 receptor to negatively regulate lung ILC2 cell differentiation and function.

Graphical Abstract
graphical abstract
Supplemental material

View Supplemental Figures and Tables (clean)

Version history
  • Version 1 (September 22, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts